B-type natriuretic peptide and glycaemia: An emerging cardiometabolic pathway?

Diabetologia

Volumn 55, Issue 5, 2012, Pages 1240-1243

  Welsh, P ^a   McMurray, J J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adiponectin; ANP. BNP. Diabetes; Glycaemia; Insulin sensitivity; IVGTT. Lipolysis; Natriuretic peptides

Indexed keywords

ADIPONECTIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C PEPTIDE; GLUCOSE; INSULIN; PLACEBO;

BLOOD GLUCOSE MONITORING; CAPILLARY PERMEABILITY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FAILURE; HEART MUSCLE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URINARY EXCRETION;

GLUCOSE TOLERANCE TEST; HUMANS; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN;

EID: 84862578295     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2515-3     Document Type: Review

References (24)

1. Chidsey CA, Harrison DC, Braunwald E (1962) Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med 267:650-654
2. Mizock BA (1995) Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 98:75-84
3. Birkenfeld AL, Budziarek P, Boschmann M et al (2008) Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 57:3199-3204
4. Polak J, Kotrc M, Wedellova Z et al (2011) Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls. J Am Coll Cardiol 58:1119-1125
5. Burgess MD, Moore KD, Carter GM et al (2009) C-type natriuretic peptide receptor expression in pancreatic alpha cells. Histochem Cell Biol 132:95-103
6. Uehlinger DE,Weidmann P, Gnadinger MP et al (1986) Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol 8:1122-1129
7. Muller D, Schulze C, Baumeister H, Buck F, Richter D (1992) Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry. Biochemistry 31:11138-11143
8. Birkenfeld AL, Boschmann M, Moro C et al (2006) β-Adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J Clin Endocrinol Metab 91:5069-5075
9. Heinisch BB, Vila G, Resl M et al (2012) B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. Diabetologia. doi:10.1007/s00125-011-2392-1
10. Muller M, Holmang A, Andersson OK, Eichler HG, Lonnroth P (1996) Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance test. Am J Physiol 271(6 Pt 1):E1003-E1007
11. McKay MK, Huxley VH (1995) ANP increases capillary permeability to protein independent of perfusate protein composition. Am J Physiol 268:H1139-H1148
12. Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63-F72
13. Kaneko JJ, Mattheeuws D, Rottiers RP, van Der Stock J, Vermeulen A (1978) The effect of urinary glucose excretion on the plasma glucose clearances and plasma insulin responses to intravenous glucose loads in unanaesthesized dogs. Acta Endocrinol (Copenh) 87:133-138
14. Salomaa V, Havulinna A, Saarela O et al (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 5:e10100
15. Pfister R, Sharp S, Luben R et al (2011) Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med 8:e1001112
16. Khan AM, Cheng S, Magnusson M et al (2011) Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 96:3242-3249
17. Miyashita K, Itoh H, Tsujimoto H et al (2009) Natriuretic peptides/ cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58:2880-2892
18. Wannamethee SG, Welsh P, Whincup PH et al (2011) High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil 18:65-71
19. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A et al (2009) Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 53:2070-2077
20. Ang DS,Welsh P, Watt P, Nelson SM, Struthers A, Sattar N (2009) Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. Clin Sci (Lond) 117:41-48
21. Schnabel R, Messow CM, Lubos E et al (2008) Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 29:649-657
22. Kenny AJ, Bourne A, Ingram J (1993) Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J 291:83-88
23. Gu J, Noe A, Chandra P et al (2010) Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi). J Clin Pharmacol 50:401-414
24. Chen HH, Cataliotti A, Burnett JC Jr (2001) Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: insights from experimental heart failure. Curr Hypertens Rep 3 (Suppl 2):S15-S21